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ABSTRACT 
 
     The high cost of feed and increasing necessity to reduce nitrogen (N) waste in dairy 
production systems has driven research in the area of improving milk protein synthesis 
and overall efficiency of N utilization in lactating dairy cows.  One strategy that has 
been investigated is reducing the total crude protein (CP) level of the diet while 
supplementing the ration with limiting amino acids (AA) for milk production.  
However, currently there is not enough information on the effects of increasing 
absorptive supply of certain individual AA on productive performance and mammary 
metabolism in high producing lactating dairy cows.  Specifically, histidine (His) has 
been shown to be a limiting amino acid in grass fed lactating dairy cows and to alter 
fat secretion under certain conditions.  In one published study in which the 
nonessential AA proline (Pro) was infused into the duodenum of two cows, a 
significant increase in milk protein output and a reduction in arginine (Arg) uptake by 
the mammary gland were observed.  The objective of this study was to determine the 
effect of abomasal infusion of His and Pro, separately and in combination, on 
productive performance and mammary amino acid utilization in high producing 
lactating dairy cows.  
     Four rumen-fistulated Holstein cows (52 ± 16 DIM) with indwelling intercostal 
arterial catheters were used in a 4 × 4 Latin square experiment. Experimental 
treatments were continuous abomasal infusion of water (Control), His (H, 10g/d), Pro 
(P, 20 g/d), and His (10 g/d) + Pro (20 g/d)(H+P), with 7-d treatment periods. Cows 
were fed a TMR (15.6 % CP, 2.7 Mcals/kg ME) once per day for ad libitum intake, 
and refusals were measured and analyzed.  The CNCPS v6.1 was used to formulate a 
diet to exceed the metabolizable energy requirement, provide 95% of the predicted 
  
metabolizable protein requirement, and supply adequate amounts of all essential 
amino acids, except Arg.  
     Compared to the Control treatment, abomasal infusion of Pro decreased dry matter 
intake (DMI) by 1.8 kg/d and improved feed efficiency (P ≤ 0.05) by 0.16 kg 3.5% 
FCM per kg dry matter.  Fat corrected milk (FCM) yields were not affected by 
treatment (51.8 kg/d, TRT C; 50.6 kg/d, TRT H; 49.0 kg/d TRT H+P; 52.4 kg/d TRT 
P).  Abomasal infusion of His resulted in no difference in milk yield or composition, 
and there was no effect of Pro infusion on protein and fat contents and yields.   Pro 
infusion increased lactose percentage (P ≤ 0.05) but not yield. The lactose response 
suggests that longer infusions might have resulted in increased milk yield. Mammary 
blood flow, expressed as L plasma/L milk, was not significantly different among 
treatments; though, Pro infusion increased blood flow by 14% relative to the control 
treatment (694.8 vs. 606.8 L plasma/L milk for P and C, respectively).  Arterial 
concentration of His tended to be higher for His infusion than for both water and Pro 
infusions.  The AV differences for all EAA were not affected by AA infusion; 
however, AV differences for Asp, Cys, Glu, and Cit were numerically lowest for Pro 
infusion, with no changes for other NEAA.  Compared to the Control infusion, His 
infusion decreased extraction efficiency of His by the mammary gland.  Although the 
P treatment did not significantly affect arterial concentration, AV difference, or 
extraction rate of Pro or Arg when compared to values for the control, it appears that 
Pro infusion tended to alter extraction efficiency and mammary uptake of Cit and Val.   
     Results of this experiment suggest that His does not limit milk production or milk 
protein synthesis in high producing lactating dairy cows fed corn silage based rations.  
Lactation performance and feed efficiency were not improved by abomasal infusion of 
His and Pro, simultaneously.  Unlike results of other studies, increased absorptive 
supply of both His and Pro did not increase milk protein synthesis in this experiment.  
  
Further, abomasal infusion of Pro did not reduce Arg uptake by the mammary gland, 
which is not consistent with other experiments in which Pro was infused postruminally 
in lactating cows and goats.  However, this work does suggest that postruminal 
supplementation of Pro might improve feed efficiency and alter milk fat secretion in 
high producing dairy cows in early lactation.   
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CHAPTER ONE: LITERATURE REVIEW 
 
Introduction 
     Milk protein has become a topic of significant interest due to its high nutritive and 
economic value, relative to other milk components.  It is essential to the 
manufacturing of cheese and contributes to the many healthful properties of dairy 
products.  The implementation of milk pricing schemes that accentuate the value of 
milk protein is another incentive prompting research of nutritional factors influencing 
milk composition and regulation of milk protein synthesis.  In addition to the potential 
economic and nutritional benefits, there exists the possibility of reducing nitrogen (N) 
waste by improving efficiency of conversion of feed N to milk protein.  Improving this 
efficiency by determining appropriate feeding strategies could reduce the 
environmental impact of the dairy industry, which remains under scrutiny by 
government agencies, research groups, and the media.   
     Current literature in the area of milk protein emphasizes a positive response in 
production of milk protein yield associated with increased intake of energy or crude 
protein (CP) (DePeters and Cant, 1992; Emery, 1978; Jenkins and McGuire, 2006).  
Although amount and source of dietary protein have been shown to affect the protein 
content of milk, this effect is modest and variable (Jenkins and McGuire, 2006).   
According to the review written by Emery, milk protein content increases 
approximately 0.02% for each 1% increase in dietary protein (Emery, 1978).  
Nonetheless, overfeeding N to dairy cows is costly for the producer and harmful for 
the environment.  Therefore, it is no longer feasible to increase milk production or 
milk protein synthesis by feeding diets with high levels of CP.      
     Current approaches to reduce or optimize N inputs without decreasing milk 
production involve careful formulation of diets in which not only metabolizable 
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protein (MP) requirements are met, but also individual amino acid (AA) requirements 
for milk protein synthesis (Lapierre et al., 2007).  Amino acids that are taken up by the 
lactating mammary gland are the building blocks of milk protein as well as other 
structural and enzymatic proteins.  Incomplete understanding of how they influence 
metabolism within the mammary gland and production of milk components presents a 
serious challenge to nutritionists whose research is focused on the identification of AA 
that limit milk protein synthesis.  If certain limiting AA are not being supplied to the 
mammary gland in sufficient amounts, postruminal delivery of these nutrients might 
be the most effective strategy to optimize AA supply for milk production without 
overfeeding N (Rogers et al., 1987).  This strategy could be beneficial only if the 
microbial protein contribution to MP supply is not compromised and energy supply 
supports high levels of milk production (Doepel et al., 2004).     
     Results of experiments designed to determine effects of postruminal administration 
of individual or mixtures of AA are difficult to interpret, as the response observed 
when correcting a limitation might resemble one imposed by creating an imbalance.  
Although abomasal or duodenal infusion of casein has been used extensively to 
demonstrate a positive response in milk and milk protein production by providing 
more AA to the small intestine, the results are inconsistent and appear to depend on 
diet composition and production level of the animals (Clark et al., 1977; Derrig et al., 
1974; Mackle et al., 1999; Spires et al., 1975).  It is likely that postruminally infused 
casein or essential amino acid (EAA) mixtures are effective in supplying some AA 
that are limiting while providing the small intestine with others that were already in 
adequate supply.  
     Essential amino acids, individually and as a group, have been the common focus of 
experiments in which AA supply in lactating dairy cows is perturbed by postruminal 
supplementation of nutrients (Schwab et al., 1992; Bequette et al., 2000; Misciatelli et 
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al., 2003).  Histidine (His) has received attention as an EAA found to be limiting for 
milk protein production when grass silage-based diets are supplemented with cereal 
concentrates (Huhtanen et al., 2002; Kim et al., 2001; Korhonen et al., 2000; 
Vanhatalo et al., 1999).  Additionally, His has been the subject of experiments in 
which removal of the AA from an infused mixture resulted in decreased milk protein 
yield, increased milk fat yield and a reduced concentration of His in plasma (Bequette 
et al., 2000; Weekes et al., 2006).  Further, a novel rumen bacterium Allisonella 
histaminiformans, isolated in ruminal fluid of lactating dairy cows fed a diet with 9.8 
kg grain, has been shown to utilize His as its sole energy source to produce histamine, 
a potent vasodilator involved in local immune responses (Garner et al., 2002).  
Conversion of His to histamine in the rumen might reduce the amount of His 
contributing to absorbable protein in the small intestine and could subsequently limit 
milk protein synthesis in animals being fed diets supplemented heavily with soluble 
protein. 
     Studies designed to determine the effects of postruminal supplementation of 
nonessential amino acids (NEAA) are not well documented.  Casein, the main protein 
found in milk, is rich in the NEAA proline (Pro), glutamate (Glu), and glutamine (Gln) 
(Swaisgood, 1995).  The mammary gland extracts these nutrients in deficit of the 
amount that is secreted in milk (Mepham, 1982).  In order to meet the Pro requirement 
for milk protein synthesis, intracellular arginine (Arg) and ornithine (Orn) are 
metabolized to produce Pro, which is accompanied by a considerable loss of N 
(Alumot et al., 1983).  Pro synthesis via Arg metabolism might represent one or more 
rate-limiting steps that affect the efficiency and/or maximum capacity of milk protein 
synthesis.      
     More research focused on changes in mammary AA metabolism and milk 
component synthesis in response to increased postruminal supply of individual and 
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combined AA is needed.  In theory, it would be beneficial to decrease total protein 
intake and supplement limiting AA to improve efficiency of N utilization in dairy 
cows.  However, current literature is lacking conclusive information on the effects of 
postruminal supplementation of EAA aside from Lys and Met, and NEAA 
supplementation on productive performance and AA utilization.  Therefore, the focus 
of this thesis will be observed responses to increasing abomasal supply of one EAA 
His and one NEAA Pro.     
 
Overview of Milk Protein Synthesis 
     On average, bovine milk contains between 3 to 3.5% of protein.  Milk-specific 
proteins include caseins, which constitute approximately 80% of bovine true protein, 
and whey proteins, which represent the remaining 20% (Bordin et al, 2001).  Caseins 
are phosphoproteins that precipitate from skim milk at a pH of 4.6 at 20oC and 
comprise proteins from four gene expressions: αs1-, αs2-, β-, and κ-caseins (Swaisgood, 
1995).  Whey proteins, which correspond to the serum fraction of milk protein, 
include β-lactoglobulin, α-lactalbumin, serum albumin, immunoglobulins, lactoferrin, 
and proteose-peptone.  The high quality of casein and whey proteins is indispensable 
to the nutritional, growth-stimulating, and immunological benefits of milk 
consumption (De Wit, 1998).  The AA composition of milk protein is relatively 
constant among many variables, including diet (Clark, 1975).     
     Biosynthesis of milk proteins is a complex metabolic process that occurs in 
mammary secretory cells.  The overall mechanism of milk protein synthesis is nearly 
the same as protein synthesis that occurs in other body tissues.  Full expression of milk 
protein genes is the result of efficient transcriptional, translational, and secretory 
components, along with an optimal supply of AA and energy.  Rate of synthesis of 
milk proteins largely depends on the concentration of pertinent mRNAs, which are 
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affected by rate of transcription and stability (Mepham et al., 1998).  The onset of 
transcription, regulated by the hormones dexamethasone and prolactin, drives mRNA 
production to make proteins.  Additionally, it has been suggested that steps involved in 
translation initiation, regulated by insulin and AA, are rate-limiting for milk protein 
production (Cant et al., 1999).   
     Other factors that can influence milk protein yield and content in dairy cows 
include stage of lactation, breed, parity, disease, environmental temperature, and 
nutrition (DePeters and Cant, 1992).  Nutritional factors that have been researched 
most extensively consist of energy intake and amount and source of dietary protein or 
AA (Jenkins and McGuire, 2006).  The AA supply to the mammary gland is crucial to 
support synthesis of not only milk proteins, but also structural and enzymatic proteins 
that affect the production of other milk components.  The mammary gland appears to 
be able to regulate its supply of nutrients through changes in blood flow, extraction 
efficiency of AA, and other regulatory mechanisms (Lacasse et al., 1996; Bequette et 
al., 1998; Bequette et al., 2000).       
 
Amino Acid Uptake and Utilization in Mammary Epithelial Cells 
     Milk proteins are synthesized from AA that are either delivered to the mammary 
gland via the bloodstream or produced within secretory cells.  Uptake of AA, which is 
influenced by extraction rate of the AA and mammary blood flow (MBF), and the 
intracellular metabolic conversions of these substrates are essential to the production 
of milk proteins.  As Mepham (1982) has described in detail, upon being taken up into 
a mammary secretory cell, AA might pass unaltered into milk, blood, or lymph, 
undergo polymerization to form milk proteins that are secreted via exocytosis, be 
retained to form structural proteins or enzymes, or enter into one of many metabolic 
reactions that yield CO2, urea, NEAA, and other substrates.   
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     The high level of protein synthesis and AA metabolism that occurs in the lactating 
mammary gland is supported by active AA transport systems.  Several key AA 
transport systems have been identified in bovine mammary tissue (Baumrucker, 1984; 
Baumrucker, 1985; Shennan et al., 1997).  Transport of cationic AA, Arg and Lys, is 
carried out through a shared saturable mediated system, which has been shown to 
operate independent of other AA transport systems and to be inhibited competitively 
by these AA or Orn (Baumrucker, 1984).  Most of the other AA transport systems, 
including A and ASC that transport most of the neutral AA, have been shown to rely 
on the transmembrane sodium gradient, which is maintained by sodium-potassium 
ATPase activity, to concentrate AA inside the cell (Baumrucker, 1985).  Therefore, 
many of the AA transport systems require an energy source to establish and maintain 
concentration gradients of AA (Hanigan et al., 2001). The presence of the N system, 
which transports Gln, His, and Asn into mammary cells, and the Anionic AA system 
in bovine mammary tissue have been postulated due to strong indirect evidence 
(Baumrucker, 1985).   Amino acid transport across the cell membrane is considered 
bi-directional (Baumrucker, 1984, 1985), and it appears that efflux of AA from 
mammary cells can be driven by intracellular concentrations of AA (Bequette et al., 
2000).  The extent to which nutrient availability for milk synthesis is limited by the 
lack of or competition of specific AA transport systems within the mammary gland 
remains unclear.   
     The AA have been categorized according to their metabolic fate within the 
mammary gland, which corresponds to the amount taken up by mammary epithelial 
cells relative to the amount that is secreted in milk protein (Mepham, 1982; Lapierre et 
al., 2005).  The EAA, which cannot be synthesized within the body, are taken up by 
the mammary gland in amounts that are approximately equal to or greater than the 
amounts that are secreted in milk.  Amino acids such as Arg, Lys, and the BCAA Ile, 
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Leu, and Val, are often grouped together because they are extracted in quantities that 
exceed their output in milk.  In addition, hepatic extraction of Lys and the BCAA is 
low compared to that of other AA (Lapierre et al., 2005).  Results from bovine 
mammary explant experiments using [14C] Ile, Leu, and Val have shown that the 
carbon skeletons of these AA are catabolized to produce TCA cycle intermediates, 
CO2, and NEAA (Wohlt et al., 1977).  There is sufficient evidence to support that 
BCAA are involved in several key functions in mammary epithelial cells, including 
providing residues for milk protein, being oxidized to produce CO2 and energy, and 
donating carbon to be incorporated into NEAA (Mepham, 1982; Bequette et al., 
2006).   
     Other EAA, notably Met, His, Phe, Tyr, and Trp, are catabolized mainly by the 
liver and are extracted by the mammary gland in amounts approximately equal to what 
is secreted in milk (Lapierre et al., 2007).  These AA, especially Phe and Tyr, are often 
used as markers to estimate mammary blood flow (MBF) indirectly via the Fick 
Principle technique because they are assumed to be incorporated directly from arterial 
plasma into milk protein with very little intracellular metabolism occurring (Verbeke 
et al., 1972; Davis et al., 1988).   
     The NEAA are taken up by the mammary gland in insufficient quantities to 
account for their output in milk.  This deficit is corrected mainly by intracellular 
synthesis of these AA by carbon, sulfur, and N sources, including some EAA 
(Bequette and Backwell, 1997; Wohlt et al., 1977).  Arg, along with Orn and Cit, 
which are extracted by the mammary gland but are not incorporated into milk protein, 
have been shown in perfused sheep and goat gland experiments to contribute 
approximately 20% of Pro residues in casein (Verbeke et al., 1968; Roets et al., 1974).  
Individually, Glu, Gln, and Pro account for approximately 10% or more of bovine 
milk protein (Swaisgood, 1995).  Therefore, it seems plausible to assume that the 
   8 
intracellular synthesis of these AA constitutes an important element of milk protein 
secretion.  
 
Efficiency of AA Utilization for Milk Protein Synthesis in Lactating Dairy Cows 
     Lactating dairy cows utilize AA to support several important functions.  The 
animal first partitions AA to fulfill a maintenance requirement.  The remaining supply 
of digested and absorbed AA is used to support deposition of body protein, fetal 
growth, gluconeogenesis, or synthesis of milk protein (Tamminga and Oldham, 1980).  
Nonruminant animals rely mostly on AA present in the diet to meet these 
requirements.  The profile of AA that is absorbed from the gastrointestinal tract 
closely resembles the profile in the diet consumed.  Therefore, it is relatively simple to 
correct a deficiency of a single AA in most nonruminant species by supplementing it 
directly into the diet (Lapierre et al., 2006).   
     Ruminant species, however, possess a unique environment in their rumen, in which 
dietary rumen degradable protein (RDP) and free AA are subject to rapid degradation 
by action of microbial peptidases and deaminases (Leng and Nolan, 1984).  Rumen 
bacteria and protozoa can use these products for growth and incorporation into new 
proteins if sufficient energy is available to support growth and other functions of 
rumen microbes.  The breakdown of peptides and free AA in the rumen also causes 
ammonia production and loss from the rumen (Wallace, 1996).    
     Microbial protein synthesized in the rumen continues through the gastrointestinal 
tract and can contribute up to 66% of the nonammonia nitrogen (NAN) that is 
absorbed in the small intestine (Clark et al., 1992).  Duodenal AA flow consists of 
mainly rumen undegradable protein (RUP) and microbial protein; however, 
endogenous secretions might contribute up to 30% of this flow (Lapierre et al., 2006, 
Marini et al., 2008).  Absorbed AA are transported to the liver where some are 
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removed from the bloodstream, and a new profile of AA is carried through general 
circulation and is utilized by tissues for maintenance or productive purposes.  
Alterations in the pattern of AA supply in the digestive tract and liver challenge the 
ability to estimate the efficiency at which individual dietary AA are utilized for milk 
protein synthesis (Doepel et al., 2004).   
     Better prediction of milk protein secretion given a known metabolizable protein 
(MP) supply is necessary for balancing a ration that will effectively meet the targeted 
level of performance without overfeeding nutrients (Lapierre et al., 2007).  It is 
currently understood that the efficiency of converting dietary N into milk is 
approximately 25 to 35% (Bequette et al., 1998; Doepel et al., 2004).  Both the 
National Research Council (NRC, 2001) model and the Cornell Net Carbohydrate and 
Protein System (CNCPS, Fox et al., 2004) use fixed efficiencies of conversion of MP 
supply for milk production.  The NRC uses a single transfer coefficient for milk 
production of 67% and recommends that the two EAA Lys and Met are included in the 
diet at 7.2% and 2.4% of MP supply, respectively (NRC, 2001).  The CNCPS 
calculates MP requirements from milk yield and milk protein content, and MP is 
converted to milk protein with a fixed efficiency of 67%, which matches the NRC 
value (Tylutki et al., 2008).  Metcalf et al. (2008) tested the accuracy of this transfer 
coefficient and found that 0.68, the value used by the Agricultural Food Research 
Council (1993), is a reasonable estimate for the efficiency of conversion of MP to milk 
protein for diets limiting in MP supply.  However, the authors suggest that an 
efficiency value of 0.63 be used when MP supply is close to matching requirements 
(Metcalf et al., 2008).  Transfer coefficients for individual AA for maintenance or 
lactation used by CNCPS are shown in Table 1.  The efficiencies of utilization of 
individual AA for lactation are based on the uptake to output ratio of each AA across 
the mammary gland (Fox et al., 2004).  
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Table 1.  Efficiencies of utilization of absorbed AA for physiological functions used 
by CNCPS.  (Fox et al., 2004)   
 
Amino acid Arg His Ile Leu Lys Met Phe Thr Val 
Maintenance 0.85 0.85 0.66 0.66 0.85 0.85 0.85 0.85 0.76 
Pregnancy 0.38 0.32 0.32 0.42 0.53 0.35 0.48 0.57 0.32 
Lactation 0.35 0.96 0.66 0.66 0.82 1.00 0.98 0.78 0.62 
 
 
     An incomplete understanding of ruminant amino acid metabolism in mammary and 
extramammary tissues presents a difficult task to researchers that are working to 
enhance models that predict nutrient requirements for optimum milk yield and 
composition of lactating dairy cows.  Recently it has been proposed to incorporate 
variable factors for transfer efficiencies of absorbed AA into predictive models.  This 
concept is based on empirical evidence suggesting a decline in marginal efficiency of 
conversion of AA to milk protein as AA supply approaches estimated requirement 
(Doepel et al., 2004; Lapierre et al., 2006).   
     Doepel et al. (2004) utilized data from 59 trials in 40 published studies involving 
postruminal or intravenous infusion of casein or free AA to fit both a segmented-linear 
model and a logistic model to determine estimates of efficiency of conversion of AA 
into milk protein.  The segmented-linear model demonstrated individual fixed 
efficiencies of utilization of AA for lactation ranging from 0.59 (Arg) to 0.95 (His), 
below the breakpoint at which AA were at optimal supply.  The logistic model showed 
that efficiency of conversion of AA for milk followed a diminishing return pattern as 
total digestible AA supply was increased, which is represented in Table 2.  Although, 
the total AA supply used to estimate the efficiency of conversion of AA to milk did 
not account for utilization by splanchnic and hepatic tissues.  According to both 
models, taking into account all 59 trials, Arg was the least efficiently used AA for 
lactation and His was the most efficiently used AA (Doepel et al., 2004).  His is one of  
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Table 2. Efficiencies of utilization1 of AA for lactation after discounting maintenance 
requirements (scurf protein, urinary protein, metabolic fecal protein, and endogenous 
protein) from total AA supply, using a logistic model. 
 
 Efficiency of conversion of AA for milk 
 % of optimum supply 
AA 50% 75% 100% 125% 
     
Arg 0.71 0.57 0.49 0.44 
His 1.09 0.88 0.76 0.68 
Ile 0.86 0.72 0.65 0.58 
Leu 0.83 0.70 0.61 0.55 
Lys 0.90 0.76 0.68 0.60 
Met 0.89 0.75 0.66 0.59 
Phe 0.75 0.61 0.53 0.48 
Thr 0.82 0.67 0.60 0.55 
Val 0.86 0.71 0.62 0.56 
Adapted from Doepel et al., 2004. 
1Calculated from AA in milk as a function of AA available for milk 
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the AA that is directly incorporated into milk protein with very little intracellular 
metabolism, and this efficiency of conversion adds to the justification of why His 
might limit milk protein synthesis. 
 
Identifying Limiting Amino Acids for Milk Production in Ruminants 
     The need to improve efficiency of utilization of MP and to avoid overfeeding N in 
ruminants has driven research in the area of identifying limiting AA for production. 
Since AA supply to the mammary gland is dependent upon various factors including 
diet, absorptive capacity, metabolism within other tissues, MBF, and abundance and 
activity of AA transporters, it is often difficult to predict how cows will respond to 
increased absorptive supply of individual AA (Bequette et al., 1998; Hanigan et al., 
2001; Cant et al., 2003).  Although identification of AA limitations is more difficult in 
ruminant species than in nonruminant species, the level of understanding in the field 
of amino acid requirements in ruminants is growing. 
     Numerous AA addition studies have been performed in order to determine the 
effect of supplementing individual potentially limiting EAA for milk production and 
milk protein synthesis (Schwab et al., 1992; Pisulewski et al., 1996; Korhonen et al., 
2000).  The observed responses in milk and protein yields of these and similar studies 
are often small and highly dependent on the MP and AA supply of the experimental 
diet (Hanigan et al., 2001).  It is important to note that when a protein sufficient diet is 
used, supplementation of AA usually does not result in a significant response.  This 
concept of diminishing marginal efficiency as AA supply approaches the required 
amount has been well substantiated (Doepel et al., 2004).   
     Methionine and Lys appear to be the most commonly investigated limiting AA in 
conventional dairy cow rations.  Studies have suggested that these two AA are the 
most limiting AA when cows are fed corn and alfalfa based commercial rations, and  
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that optimal concentrations of these AA in MP are required to increase milk protein 
synthesis (Schwab et al., 1976).  Although Met and Lys supplementation has been 
shown to increase milk and milk protein yield in certain feeding and management 
situations (Rogers et al., 1987; Schwab et al., 1992; Pisulewski et al., 1996), the level 
of the response is not always consistent, especially when AA are included in the diet 
as rumen protected supplements (Colin-Schoellen et al., 1995; Rulquin et al., 1997; 
Misciatelli et al., 2003).  Since all 20 AA are required for milk protein synthesis and a 
deficiency in any one of these AA could result in lower rates of mRNA translation if 
the AA is at less than saturating concentrations, it is plausible that multiple AA might 
be rate limiting for milk protein synthesis at any given time (Bequette et al., 2003). 
     Also, it has been suggested that any of the synthetic or catabolic reactions, 
involving various AA and energy substrates, that occur in the lactating mammary 
gland might represent a rate limiting step in the process of milk protein synthesis 
(Hanigan et al., 2001; Bequette et al., 2003).  There is a need for more research on the 
role of specific NEAA in protein nutrition and mammary metabolism.  Although these 
AA can be synthesized from EAA in the mammary gland and other tissues, these 
processes might represent rate limiting steps in milk protein synthesis (Basch et al., 
1997).  Additionally, adequate supply of EAA for NEAA synthesis is most likely 
affected by utilization in biochemical pathways that generate energy metabolites for 
the cell (Bequette and Nelson, 2006).  For example, results of a mammary gland 
explant incubation study showed that approximately 55% of galactose for lactose 
synthesis is derived from non-glucose sources (Bequette et al., 2005).  The authors 
estimated that between 4 to 12% of that galactose came from EAA catabolism 
(Bequette and Nelson, 2006).  Although some of these metabolic pathways have been 
established, the rates at which they occur are not well defined, which further limits the 
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confidence with which AA can be supplemented in rations to meet requirements for 
synthesis of protein and other components of milk.   
 
Histidine: A Limiting Amino Acid? 
     His is an EAA that is removed extensively by the liver and is characterized by a 
0.98 ratio of milk output to net post-liver supply (Lapierre et al., 2005).  According to 
the NRC (2001), His in corn silage and grass silage comprises approximately 5.7 and 
5.1% of total EAA, respectively, and His in rumen bacteria and protozoa represents 
4.1 and 3.6% of total EAA, respectively.  Compared to the other EAA, the proportion 
of His in total EAA of these sources is similar to the value for Met and Trp, and these 
values are less than for all other EAA (NRC, 2001).  His has been the subject of 
numerous research reports as a potential limiting AA for milk and protein production 
(Vanhatalo et al., 1999; Korhonen et al., 2000; Kim et al., 2001; Huhtanen et al., 
2002); however the animal models and dietary conditions used for these experiments 
do not represent the majority of intensive dairy production systems in the US.  For 
example, many of these experiments were conducted in Europe with cows consuming 
grass silage based rations and producing less milk.   
     It is possible that typical commercial diets in the US can provide lactating dairy 
cows with adequate RDP for rumen microbes and RUP to the lower GI tract to supply 
the animal with adequate amounts of His for high levels of milk production and 
protein synthesis.  However, there are very few published studies in which a potential 
His limitation in high producing lactating cows was investigated.  Furthermore, a 
novel rumen bacterium Allisonella histaminiformans has been shown to utilize His as 
its primary source of energy (Garner et al., 2002).  This Gram-negative bacterium, 
which is resistant to monensin, grows rapidly by converting His to histamine and CO2 
via decarboxylation of His.  Histamine is a potent vasodilator and arterial constrictor 
   15 
that is naturally found in tissues and blood (Chavance, 1946).  Additionally, it has 
received attention as one of the contributing factors in cases of bovine laminitis 
(Nocek, 1997; Garner et al., 2004).  Histamine production in the rumen by A. 
histaminiformans appears to be diet-dependent, as conversion of His to histamine was 
very low in dilutions of rumen fluid from cows fed only timothy hay and was 
significantly higher as grain was included in the diet (Garner et al., 2002).  
Furthermore, extracts of both corn and alfalfa silage have been shown to stimulate 
growth and histamine production of A. histaminiformans, although alfalfa silage was 
most effective (Garner et al., 2004).  Inclusion of high quality alfalfa and grain in the 
diet might lead to higher rates of histamine production by these bacteria in the rumen, 
which could limit absorptive supply of His.     
     The most recent experiments in which His was shown to be limiting for milk 
production or milk protein synthesis were conducted using lactating cows being fed 
grass silage based diets (Vanhatalo et al., 1999; Korhonen et al., 2000; Kim et al., 
2001; Huhtanen et al., 2002).  The cows in these studies were in early lactation, and 
reported averages of daily milk production ranged from 22.9 to 28.8 kg, which is less 
than the typical high producing dairy cow in the US.  However, under these particular 
experimental conditions, the authors observed increases in either milk or protein yield, 
or both, when at least 6 g of His was continuously infused into the abomasum of the 
animals.  The magnitude of the response in milk production varied by experiment, and 
researchers have reported increases of milk protein yield ranging from 26 g/d, when 
6.5 g of His was infused into the abomasum (Vanhatalo et al., 1999), to 111 g/d, when 
6 g of His was infused intravenously (Kim et al., 2001).  Korhonen et al. (2000) 
reported a linear increase in daily milk, protein, and lactose yield with increasing 
doses of abomasal His, from 0 to 6 g.  The predicted MP supply of this experimental 
diet relative to predicted requirement was not reported.     
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     Correction of a His deficiency has been shown commonly in His subtraction 
experiments to stimulate milk and milk protein production while decreasing 
production of milk fat (Bequette et al., 2000; Cant et al., 2001; Weekes et al., 2006; 
Purdie et al., 2009).  A recent study, in which mixtures of AA with or without His 
were infused intravenously in four Holstein cows in mid lactation, showed that milk 
protein yield decreased 100 g/d with His deficiency, which was accompanied by an 
increase in milk fat by 95 g/d (Purdie et al., 2009).  Proposed mechanisms by which a 
His deficiency might stimulate milk fat production include faster rate of MBF to 
compensate for low His concentration in plasma (Bequette et al., 2000), a change in 
concentrations of milk fat precursors in circulation due to a more systemic response to 
the deficiency, and an alteration of intracellular carbon flows associated with excess 
AA catabolism in the mammary gland (Cant et al., 2001; Weekes et al., 2006).         
     Bequette et al. (2000) conducted an experiment in which four lactating goats were 
fed a low protein ration, and mixtures including and excluding His were infused into 
the abomasum of each animal.  Responses to a His deficiency and subsequently low 
His concentration in plasma included  increased MBF and capacity of the mammary 
gland to remove circulating His along with decreased influx and efflux of His by the 
mammary gland.  Extraction efficiency of His increased from 24 to 83% when His 
supply was limiting.  The authors of this study reported that the udder appeared to 
have the ability to regulate MBF in an attempt to overcome a single AA limitation.  
Also, they implicated that the mammary gland responded to the His limitation through 
up-regulation of His extraction processes and down-regulation of those processes that 
are involved in extracting other AA.  Although this research does not shed light on the 
extent of His limitation under normal conditions, it does provide evidence to support 
adaptive capabilities of the mammary gland in response to a His limitation. 
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Proline: A Limiting Amino Acid?  
     Pro is one of the most abundant amino acids in casein, the major protein in most 
dairy products.  It constitutes approximately 10% of the total AA profile of milk 
protein; however it is taken up by the mammary gland in deficit of its output in milk 
(Mepham, 1982).  Measurement of AV differences of plasma free AA across the 
lactating mammary gland in combination with experiments involving incubation of 
mammary tissue slices has led to the discovery of a link between Arg metabolism and 
Pro synthesis.  Through a series of enzymatic steps related to the urea cycle, Pro 
precursors are synthesized in mammary secretory cells through metabolism of Arg and 
ornithine (Orn), both AA taken up in excess by the mammary gland (Clark et al., 
1975; Mepham and Linzell, 1966).     
     Though evidence in the literature refutes the presence of a complete urea cycle in 
mammary tissue, several key enzymes that are involved in the conversion of Arg to 
Pro have been identified in the lactating bovine mammary gland (Basch et al., 1996; 
Basch et al., 1997; Basch et al., 1995; Clark et al., 1975).  A proposed mechanism of 
Pro synthesis in the lactating mammary gland is presented in Figure 1.  Arginase, an 
enzyme that catalyzes the hydrolysis of Arg to Orn and urea, is expressed in lactating 
bovine (Basch et al., 1997; Clark et al., 1975) and rat (Glass and Knox, 1973; Yip and 
Knox, 1972) mammary tissue.  Ornithine-δ-aminotransferase (OAT), which catalyzes 
the conversion of Orn and α-ketoglutarate to glutamate semialdehyde and glutamate, 
respectively, is coordinately expressed in the bovine lactating mammary gland (Basch 
et al., 1995).  Glutamate semialdehyde, which is produced by activity of OAT, 
cyclizes to form Δ1-pyrroline-5-carboxylate (P5C).  The conversion of P5C to the final 
product Pro occurs via action of P5C reductase, which has been identified in both the 
mitochondrial and cytosolic fractions of lactating mammary gland cells (Basch et al., 
1996).  The enzyme P5C reductase uses NADPH, which is one of the products of  
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Figure 1. Proposed mechanism of proline production in the lactating bovine mammary 
gland. IDH = isocitrate dehydrogenase, P5C = pyrroline-5-carboxylate, OAT = 
ornithine aminotransferase, α-keto = α-ketoglutarate, and ARG = arginase. From 
(Basch et al., 1997).   
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isocitrate dehydrogenase, a Krebs cycle enzyme that converts isocitrate to α-
ketoglutarate (Basch et al., 1997).  The source of the α-ketoglutarate and NADPH 
required for intracellular synthesis of Pro is the Krebs Cycle; therefore, the two 
processes appear to be linked (Basch et al., 1997).       
     Uptake of Pro by the mammary gland is insufficient to account for Pro output in 
milk protein (Mepham, 1982), therefore intracellular Pro synthesis, which utilizes Arg 
and Orn, might represent a rate limiting step in milk protein synthesis (Bequette and 
Backwell, 1997).  Arg, which is extracted in the greatest amounts relative to milk  
protein outputs (150 to 200% excess), is a metabolically versatile AA.  A simple 
schematic of sources and metabolic fates of Arg is presented in Figure 2.  Since 
approximately 20% of Pro is synthesized within mammary cells, close to half of which 
appears to be due to utilization of Arg (Verbeke et al., 1968), it might be important to 
consider other metabolic functions that require this multifunctional AA.  Not only 
does Arg contribute as a building block of proteins, but also it serves as a precursor for 
synthesis of nitric oxide (NO), urea, polyamines, agmatine, creatine, and glutamate 
(Wu and Morris, 1998; Morris, 2006).  The role of Arg in production of NO is 
important because NO is considered a vasorelaxant that has been shown to control 
blood flow to the mammary gland (Lacasse et al., 1996; Lacasse and Prosser, 2003).  
Although close arterial infusion of the NO donor diethylamine NONOate increased the 
rate of MBF by 250% in lactating goats, the short-term increase in MBF did not affect 
milk production (Lacasse and Prosser, 2003).  Dietary supplementation of a NO donor 
in lactating sows was shown to enhance weight gain in nursing neonates (Kim and 
Wu, 2009).  Polyamines, which are synthesized from Arg and Orn, are essential for 
normal cell growth and can regulate the function of DNA, RNA, and other proteins 
(Igarashi and Kashiwagi, 2000).  Exploitation of the regulatory roles of Arg in  
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Figure 2. Sources and metabolic products of arginine. Adapted from (Morris, 2006).   
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mammary gland growth and milk synthesis might be an effective strategy to improve 
milk production (Kim and Wu, 2009).       
     Results from two published studies investigating the effects of duodenal Pro 
infusion in ruminants suggest that increasing absorptive supply of Pro might have 
decreased the Arg requirement of the mammary gland.  To test whether or not 
increased Pro supply to the small intestine affects milk composition and uptake of AA 
by the mammary gland, Bruckental et al. (1991) performed an experiment on a small 
group of early and mid lactation Israeli-Fresian cows.  Postruminal infusion of Pro did  
not affect milk protein concentration and protein yield during early lactation; however, 
milk fat content and 4% fat-corrected milk yield increased.  Bruckental et al. also 
observed a significant decrease in Arg uptake by the mammary gland when Pro was 
infused, suggesting that the Arg requirement for milk protein synthesis was reduced 
with increased absorptive Pro supply (Bruckental et al., 1991).  Alumot et al. (1983) 
observed similar responses when they infused Pro into the duodenum of two lactating 
goats.  These authors reported a significant increase in milk fat content (from 2.8 to 
3.2%) during Pro infusion (Alumot et al., 1983).  Although these studies provide some 
evidence that postruminal infusion of Pro might increase milk protein yield or alter 
milk composition in lactating ruminants, the experiments used small numbers of 
animals, indicating that further work is required to draw practical conclusions from the 
results.        
 
Conclusions and Objectives 
     The current literature provides a basic understanding of intracellular AA 
metabolism and milk protein synthesis in the mammary gland; however the effects of 
changing the absorptive supply of individual AA on these reactions remain unclear.  
The lactating mammary epithelial cell comprises a complex set of metabolic reactions 
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that require high levels of energy and AA, although the extent to which these reactions 
might limit the rate of milk protein synthesis is not well understood.  More research is 
needed in this area in order to determine AA requirements for milk protein synthesis 
and to identify limiting AA in high producing lactating dairy cows.  His and Pro are 
two AA that have not been investigated extensively, yet there is some evidence that 
increasing absorptive supply of each will result in higher milk protein production in 
lactating dairy cows.   
     His has been shown to increase milk production and milk protein yield in dairy 
cows fed grass silage based rations.  Furthermore, a recently isolated rumen bacterium 
A. histaminiformans, readily converts His to histamine and utilizes His as its primary 
source of energy.  Growth and histamine production by A. histaminiformans appears 
to be dependent on diet and seems to favor a rumen environment in which corn and 
alfalfa based diets that are high in grain have been fed.  It has yet to be determined 
whether or not His limits milk production in high producing lactating dairy cows fed 
corn silage based commercial diets commonly found in the US.  Duodenal infusion of 
Pro in lactating cows and goats has resulted in elevated milk protein yield and a 
significant decrease in Arg uptake by the mammary gland.  Researchers conducting 
these studies suggested that increased absorptive supply of Pro might have reduced the 
requirement of Arg for intracellular Pro synthesis within the mammary gland.   
    One of the objectives of the current experiment is to determine the effect of 
abomasal infusion of His and Pro, together and separately, on production of protein 
and other components of milk.  The second objective is to investigate the effect of 
increased absorptive supply of these AA on AV difference, uptake, and extraction 
efficiency of AA by the mammary gland.  These questions will be answered using 
high producing dairy cows in early lactation being fed a corn silage based diet that is 
formulated to be slightly deficient in MP supply.   
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CHAPTER TWO: EFFECT OF ABOMASAL INFUSION OF HISTIDINE AND 
PROLINE ON MILK COMPOSITION AND MAMMARY AMINO ACID 
UTILIZATION IN HIGH PRODUCING LACTATING DAIRY COWS 
 
ABSTRACT 
 
Histidine (His) has been shown to be a limiting amino acid in lactating dairy cows fed 
grass silage based diets and to alter fat secretion under certain conditions. A 
significant increase in milk protein output and a reduction in arginine uptake by the 
mammary gland were observed when proline (Pro) was infused into the duodenum of 
two cows. The objective of this experiment was to determine the effects of abomasal 
infusion of His and Pro on lactation performance and amino acid utilization by the 
mammary gland in cows. Four rumen-fistulated Holstein cows (52 ± 16 DIM) with 
indwelling intercostal arterial catheters were used in a 4 × 4 Latin square experiment. 
Experimental treatments were continuous abomasal infusion of water (Control, C), His 
(H, 10g/d), Pro (P, 20 g/d), and His (10 g/d) + Pro (20 g/d) (H+P), with 7-d treatment 
periods. Cows were fed a TMR (15.6 % CP, 2.7 Mcals/kg ME) once per day for ad 
libitum intake, and refusals were measured and analyzed. The CNCPS v6.1 was used 
to formulate a diet to exceed the metabolizable energy requirement, provide 95% of 
the predicted metabolizable protein requirement, and supply adequate amounts of all 
essential amino acids, except Arg. Fat corrected milk (3.5% FCM) yields were high 
and not affected by treatment (51.8 kg/d, TRT C; 50.6 kg/d, TRT H; 49.0 kg/d TRT 
H+P; 52.4 kg/d TRT P), however abomasal infusion of Pro decreased feed intake and 
improved feed efficiency by 0.17 kg 3.5% FCM per kg dry matter (P ≤ 0.05). Pro 
infusion increased lactose percentage (P ≤ 0.05) but not yield. The increase in lactose 
content suggests that longer infusions might have resulted in increased milk yield. A 
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similar effect for lactose and feed efficiency was observed for the H+P treatment. 
Abomasal infusion of His resulted in no difference in productive performance. 
Mammary blood flow, expressed as L blood/L milk, was not significantly different 
among treatments; though, Pro infusion increased blood flow by 14% relative to the 
control treatment (694.8 vs. 606.8 L blood/L milk for Pro and control treatments, 
respectively).  Arterial concentration of His tended to be higher for His infusion than 
for both water and Pro infusions (P ≤ 0.10) and was not significantly different between 
H and H+P treatments.  The AV differences for all EAA were not affected by AA 
infusion; however, AV differences for Asp, Cys, Glu, and Cit were numerically lowest 
for Pro infusion, with no changes for other NEAA.  Compared to the Control infusion, 
His infusion decreased extraction efficiency of His by the mammary gland.  Although 
the Pro infusion did not significantly affect arterial concentration, it appears that Pro 
infusion tended to alter extraction efficiency and mammary uptake of Cit and Val (P ≤ 
0.10) compared to the Control.  Results show that lactation performance and feed 
efficiency were not improved by simultaneous abomasal infusion of His and Pro.  
However, this experiment indicates that postruminal supplementation of Pro might 
increase milk fat production and feed efficiency in high producing dairy cows in early 
lactation.   
 
INTRODUCTION 
  
     Dairy products provide a unique and complete source of protein, energy, vitamins, 
and minerals for humans to consume.  Improving conversion efficiency of dietary 
nutrients into milk and its beneficial components has been a research topic of 
significant interest for decades.  Milk protein has received much attention, as it is 
valuable not only from a nutritional standpoint, but also from an economic one.  
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According to current milk pricing systems, dairy producers receive a premium for the 
protein their animals produce.  However, concern about the detrimental environmental 
impact of excessive N waste on dairy farms paired with high feed costs has prompted 
nutritionists to investigate feeding strategies that could potentially maximize milk 
protein and improve efficiency of utilization of dietary nutrients.  It has been 
suggested that the most effective strategy to reduce N losses from dairy farms is to 
improve the efficiency of feed N utilization by dairy cattle (Jonker et al., 2002).   
     Amino acid metabolism in dairy cows is complex and presents a challenge to 
researchers who aim to improve efficiency of utilization of consumed N for milk 
protein production.  The NRC model (2001) predicts milk protein yield using fixed 
efficiencies of conversion of metabolizable protein (MP) for maintenance (67%), 
pregnancy (33%), and milk production (67%).  The use of an MP system reflects the 
idea that diets can be balanced to meet requirements for absorbable protein, which are 
really AA.  It has been postulated that efficiency of conversion of AA to milk protein 
is dynamic and decreases as AA supply approaches requirement (Doepel et al., 2004).  
However, other data suggest it is difficult to alter this efficiency under typical 
production conditions (Metcalf et al., 2008).  Supply of AA to the mammary gland for 
protein synthesis is dependent upon various factors, including intracellular metabolism 
of nutrients within the mammary gland, local blood flow, and utilization of AA by 
other tissues.  Once taken up by mammary secretory cells, AA are extensively 
synthesized and degraded via transamination, transformation, and oxidation reactions 
(Bequette 1998).   
     Several of the EAA, notably Arg and the BCAA are extracted by the mammary 
gland in excess of their output in milk.  They can act as substrates for transamination 
and catabolic reactions that form intermediates for synthesis of NEAA, which are 
taken up by the mammary gland in deficit of their output in milk.  The group of AA 
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for which uptake by the mammary gland is approximately equal to secretion into milk 
protein includes Met, His, Phe, and Tyr (Mepham, 1982).   Research on identification 
of limiting AA for milk production in lactating dairy cows has indicated that Met and 
Lys are the first and second limiting AA when corn based diets are fed (Clark, 1975; 
Schwab et al., 1976; Schwab et al., 1992a; Schwab et al., 1992b).  These studies have 
focused mainly on postruminal supplementation of casein or EAA, both individual and 
in combination, and the responses in milk and protein production are variable (Derrig 
et al., 1974; Schwab et al., 1975; Mackle et al., 1999; Vanhatalo et al., 1999).     
     Histidine is an EAA that is removed extensively by the liver of dairy cows and is 
characterized by a 0.98 ratio of milk output to net post-liver supply (Lapierre et al., 
2005).  Histidine has been shown to limit milk production in dairy cows fed grass 
silage based rations (Vanhatalo et al., 1999; Korhonen et al., 2000; Huhtanen et al., 
2002).  In these studies, a significant increase in both milk yield and milk protein yield 
was observed when His was infused into the abomasum of early or mid lactation dairy 
cows.  The animals used for these experiments were producing between 22.9 and 28.8 
kg of milk per day, which is typically less than the average milk yield of high 
producing cows being fed conventional corn silage and legume based diets.  Further, a 
novel rumen bacterium Allisonella histaminiformans utilizes His as its sole energy 
source and readily decarboxylates this AA to form histamine, a neurotransmitter 
involved in local immune responses (Garner et al., 2004).  Histidine degradation by 
these rumen bacteria might limit the amount of His that is available for absorption and 
utilization for productive functions.   
     The NEAA are taken up by mammary secretory cells in amounts that are 
insufficient for milk protein synthesis.  These AA are synthesized within cells via 
catabolism of EAA that are taken up by the mammary gland in excess of their output 
in milk (Mepham, 1982).  Although Pro accounts for approximately 10% of milk 
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protein (Swaisgood, 1995), it has received little attention as a potentially limiting AA 
for production in lactating dairy cows, mainly due to the fact that it can be synthesized 
within the mammary gland (Verbeke et al., 1968).  Arginine and Orn, which are taken 
up in excess of their output in milk, contribute to intracellular synthesis of Pro (Clark 
et al., 1975).  Several key enzymes that facilitate this process, including arginase, 
ornithine aminotransferase (OAT) and Δ1-pyrroline-5-carboxylate reductase (P5C), 
have been identified in vitro in the lactating bovine mammary gland (Basch et al., 
1995; Basch et al., 1996; Basch et al., 1997).   
     Bruckental et al. (1991) infused 80 g/d of Pro into the duodenum of four dairy 
cows being fed a 14% CP diet and observed a significant increase in milk protein yield 
in the two mid lactation cows.  Proline infusion resulted in increased milk fat content 
and 4% FCM yield in all cows.  Interestingly, the authors reported that Arg uptake by 
the mammary gland decreased by 50% during Pro infusion, and they suggested that 
increased postruminal supply of Pro reduced requirements for Arg by the mammary 
gland and improved efficiency of dietary energy utilization.  In a similar experiment, 
two goats were fed a protein deficient diet and given a duodenal infusion of Pro.  In 
those goats milk fat percentage increased (4.0 vs. 2.8%), and Arg uptake was 
decreased with Pro infusion (Alumot et al., 1983).   
     Currently there is not enough evidence to determine whether or not postruminal 
supplementation of His or Pro results in higher yields or efficiency of milk or milk 
protein production in high producing dairy cows fed diets conventional to the 
Northeastern dairy industry in the US.  Additionally, information on altering AA and 
energy metabolism in the mammary gland or efficiency of utilization of dietary 
nutrients by increasing the supply of individual AA could improve current models of 
mammary metabolism (Maas et al., 1997; Hanigan et al., 2001).  If Pro synthesis 
within the mammary gland represents one or more steps that might be limiting milk 
   28 
protein synthesis, then supplying more Pro directly to the mammary gland could be 
one method of improving efficiency of milk protein production.  The objective of the 
present study is to determine lactation performance and mammary AA utilization in 
response to abomasal infusion of His and Pro and to determine if infusion of these AA 
alters the metabolism of other EAA and NEAA.   
 
MATERIALS AND METHODS 
 
Animals, Design, and Treatments 
     All experimental procedures were approved by the Cornell University Institutional 
Animal Care and Use Committee.  Four multiparous, rumen-fistulated Holstein cows 
were randomly assigned to treatments arranged in a 4 × 4 Latin square design, with 
consecutive 7-d periods.  At the beginning of the study, cows averaged 674 ± 31 kg of 
BW and were 52 ± 16 DIM (mean ± SD).  The cows were housed in individual tie 
stalls with sawdust bedding and were milked three times daily, at 0700, 1500, and 
2300 h.  Cows walked to the parlor for milking during the first five days of each 
period and were milked in their stalls with a bucket milker on the last two days of each 
period.         
     Treatments were continuous abomasal infusion of water (control; C), 10 g of His 
(H), 20 g of Pro (P), and 10 g of His plus 20 g of Pro (H+P).  Prior to the start of the 
experiment, infusion cannulae were installed via the reticulo-omasal orifice into the 
abomasum of each cow (Mackle et al., 1999).  The AA were measured and then 
solubilized in water, and the solutions were continuously infused using peristaltic 
pumps (Masterflex L/S, Model 07523-70, Cole-Parmer, Vernon Hills, IL) that were 
calibrated so that each cow received 4 L of the AA solution over a 24-h period.  
Infusates were carried via Nalgene tubing (0.5 cm i.d.), which was placed through the 
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rumen fistula and sulcus omasi into the abomasum.  Bottles with infusates were 
weighed at the beginning and end of each 24-h period to ensure consistent delivery of 
the appropriate amounts of AA.  Abomasal cannulae were checked every other day 
during the trial to verify proper placement.  Lysine-HCl (Dyets, Inc., Bethleham, PA) 
was added to the experimental infusates and continuously infused at a rate of 32.5 g/d 
to ensure that postruminal supply of Lys would not limit milk production in the 
present experiment.  This level of supplementation was based on estimated 
requirements from the CNCPS v6.1 (Tylutki et al., 2008). 
   
Diet 
     Cows were fed a basal TMR (Table 3) once per day between 0700 and 0930 for ad 
libitum intake.  The refusals were set to be 10% of the amount of feed offered and 
were measured each morning between 0600 and 0800.  Samples of TMR, orts, 
forages, and concentrate were collected twice per week, dried, composited by week, 
and analyzed for chemical composition (Dairy One Forage Lab, Ithaca, NY).  The 
Cornell Net Carbohydrate and Protein System (CNCPS) v6.1 (Tylutki et al., 2008) 
was used to formulate the ration to provide 105% of metabolizable energy 
requirements and to provide 95% of the metabolizable protein requirement.  The diet 
was formulated to have a CP content of 14.4% and to provide EAA to meet 
requirements as shown in Table 2, with the exception of Arg, which was supplied at 
95% of requirement.   
     Since Lys and Met are often regarded as first and second limiting AA for milk 
production in high producing dairy cows, Smartamine M (Adisseo, Alpharetta, GA) 
was included in the concentrate portion of the diet to satisfy the predicted Met 
requirement for the animals.  Lysine was added via continuous abomasal infusion of 
Lys- HCl to ensure that postruminal supply of Lys would not limit milk production in  
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Table 3. Diet ingredients expressed as proportion of total mixed ration dry matter and 
formulated chemical composition. 
 
Ingredient % of total ration DM 
Forage  
   Corn silage, processed 46.13 
   Mixed mostly legume silage 11.65 
   Wheat straw 1.83 
Concentrate  
   Corn grain, steam flaked 16.28 
   Wheat midds by-product 6.19 
   Soybean hulls 6.19 
   Rumen bypass soy protein1 3.68 
   Whey permeate 3.24 
   Soybean meal, 48% CP 3.00 
   Rumen bypass fat 0.82 
   Sodium bicarbonate 0.64 
   Limestone, ground 0.60 
   Salt 0.39 
   Urea 0.31 
   Calcium sulfate 0.24 
   Magnesium oxide 0.10 
   Smartamine M 0.07 
   Selenium 0.60% 0.05 
   1100 Dairy TM 0.03 
   Dairy ADE-AL/MA 0.02 
  
Chemical composition  
   CP, % DM 14.4 
   Soluble P, % CP 38.0 
   NDF, % DM 32.8 
   Lignin, % DM 7.8 
   Crude fat, % DM 5.0 
  
   Calcium, % DM 0.69 
   Phosphorus, % DM 0.40 
   Magnesium, % DM 0.26 
   Potassium, % DM 1.32 
   Sodium, % DM 0.18 
  
   ME, Mcal/kg 2.65 
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Table 4. The formulated essential amino acid balance, requirement, and supply as 
predicted by Cornell Net Carbohydrate and Protein System v6.1 for a 635 kg cow 
consuming 22.6 kg DM/d and producing 39.9 kg milk/d at 3.65% fat and 3.01% 
protein. 
 
 MP (g/d) MP AA Supply (g/d) 
 Balance Required Total Bacteria RUP 
      
Arg -7.4 158.4 151.0 90.4 60.6 
His 12.9 49.1 62.0 35.0 27.0 
Ile 2.2 122.3 124.5 76.4 48.1 
Leu -0.5 195.4 194.9 97.6 97.3 
Lys 21.7 142.6 164.4 106.6 57.8 
Met 15.0 43.0 58.0 34.8 23.2 
Phe 43.0 79.2 122.3 67.1 55.2 
Thr 37.8 79.3 117.2 72.6 44.5 
Trp 6.4 28.1 34.5 21.2 13.3 
Val -0.3 138.7 138.4 80.1 58.3 
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the present experiment.  Based on the predictions of the CNCPS, the addition of these 
two AA would have maintained a Lys: Met ratio of 2.8: 1 and balanced Lys at 7.2% of 
EAA. 
 
Milk Sampling and Analysis 
     Milk yield was measured daily via electronic parlor measurements or direct 
weighing throughout the duration of the experiment, and samples were collected at  
each milking on the last 2 d of each treatment period.  Samples were analyzed 
individually for true protein, fat, lactose, total solids, MUN, and SCC at the Northeast 
DHIA Inc. using an infrared milk analyzer (Milkoscan 6000; Foss Electric, Hillerød, 
Denmark).  Milk samples taken on the last 2 d of each period were composited by day 
and an aliquot for each composite was frozen at -15oC until analysis for NPN.  Macro-
Kjeldahl techniques were utilized to determine the NPN fraction of composited milk 
samples (Barbano and Lynch, 1991).   
     Another aliquot of each daily composite was de-fatted and used to determine milk 
AA composition.  A modified procedure of Gehrke et al. (1985) was used to acid 
hydrolyze milk samples with 6 N hydrochloric acid.  Milk samples containing 
approximately 2 mg N were freeze dried in screw top hydrolysis tubes, and 50 µL of 
125 mM norleucine and 5 ml of 6 N HCl were added.  Mixtures were flushed with N 
gas to remove O2, and were placed in boiling water for 10 minutes before being heated 
in a block heater at 110oC for 21 h.  After filtration through a Whatman 541 filter, all 
HCl was removed from a 1 ml aliquot by evaporation with N2 gas.  Approximately 0.6 
ml of sample was filtered through a 0.45 µm nylon filter into a vial and was frozen at -
15oC until analysis for AA composition.  A modified preoxidation technique using 
performic acid (Spindler et al., 1984) was employed to convert the sulfur AA cysteine 
and methionine to cysteic acid and methionine sulfone, respectively prior to acid 
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hydrolysis with hydrochloric acid.  Milk samples were analyzed by ion exchange High 
Pressure Liquid Chromatography (HPLC System Gold with 32 Karat software, 
Beckman-Coulter, Inc., Fullerton, CA) for AA composition.  Lithium based buffers 
(Li292, Li365, Li375) were used to elute AA, and AA concentrations were determined 
by absorbance at 560 nm following postcolumn derivitazation with a ninhydrin 
reagent.              
  
Measurements of Arteriovenous Difference 
     Indwelling intercostal artery catheters were installed at least six days prior to the 
start of the experiment.  The last day of each experimental period was used for 
collection of blood from an artery and vein of each animal.  Arteriovenous differences 
across the mammary gland were measured according to the procedure of Mackle et al. 
(2000).  Prior to the commencement of the experiment, an indwelling catheter (0.065 
in o.d. × 0.030 in i.d.; Micro-Renathane, Braintree Scientific Inc.) was installed in an 
intercostal artery of each cow to obtain an arterial blood sample, and patency was 
maintained for the duration of the experiment.  To collect a venous blood sample, a 
catheter (0.080 in o.d. × 0.040 in i.d.; Micro-Renathane, Braintree Scientific Inc.) was 
inserted in one of the caudal superficial epigastric veins of each animal at least 12 h 
prior to sampling and was removed immediately following collection of the last blood 
sample.   
     Cows were standing for at least 20 minutes prior to blood sampling and remained 
standing throughout collections.  Arterial and venous blood samples were obtained 
simultaneously into heparinized tubes at 1-h intervals for 12 h.  Tubes were placed in 
ice, and plasma was separated by centrifugation and collected immediately after each 
sampling.  Deproteinization of plasma was achieved by adding 0.07 ml of 50% 
sulfosalicylic acid containing the internal standard norleucine (2.5 µM) to 0.63 ml of 
   34 
plasma.  Deproteinized plasma samples were vortexed extensively, centrifuged, and 
the supernatant fractions were composited at 2-h intervals resulting in six pairs of 
arterial and venous samples per cow on the last day of each period.  Samples were 
filtered through a 0.45 µm filter and frozen at -15oC.  An automated ion-exchange 
HPLC system (HPLC System Gold with 32 Karat software, Beckman-Coulter, Inc., 
Fullerton, CA) was used to analyze plasma for AA composition.  An additional aliquot 
of plasma was collected at 1200 and 1400 on the last day of each period and frozen 
until analysis for plasma urea N (PUN).  Concentration of PUN was determined by 
enzymatic colorimetric analysis using commercial kits (Sigma Chemical Co., St. 
Louis, MO).   
 
Calculations and Statistical Analysis 
     The Fick Principle assumes that uptake of a particular substrate by the mammary 
gland is estimated by multiplying the AV difference across the udder with mammary 
blood flow (MBF).  This concept depends on the presence of a marker that is 
transferred from arterial blood to milk directly, without participating in other 
intracellular metabolic processes.  In this experiment MBF was estimated by utilizing 
the AA Phe and Tyr, because they are assumed to be secreted in milk with an output to 
uptake ratio close to 1.  The following equation used to calculate MBF was the same 
as the one reported by Mackle et al. (2000): 
 
          MBF = 
 
MPPhe and MPTyr represented the concentration of the respective AA in milk, 
multiplied by the daily milk yield.  The AVPhe and AVTyr were AV differences across 
the udder for these AA, and Hct signified hematocrit percent, which was determined 
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immediately after each blood sampling.  Extraction efficiency was calculated by 
dividing the AV difference of the AA by its concentration in arterial plasma and then 
multiplying by 100.  Mammary uptake of AA was calculated by multiplying the AV 
difference across the mammary gland by the mammary blood flow.   
     Mean values for each cow were determined for milk yield, milk composition, and 
DMI from the last two days of each treatment.  Effects of treatment were analyzed as a 
mixed model procedure of JMP (version 8.0, SAS Institute, Cary, NC), using the 
following model:  
Yijk = µ + Ci + Pj + Tk + εijk 
 
where Yijk is the dependent variable, µ is the overall mean, Ci is the random effect of 
cow, Pj is the fixed effect of period, Tk is the fixed effect of treatment, and εijk is the 
residual error.  Data and residuals were checked for normality, and these distributions 
provided further justification for using the mixed model.  Data are presented as least 
squares means.  Treatment effects were declared significant at P ≤ 0.05, and trends for 
treatment effects were declared at P ≤ 0.10.  Since treatments were not expected to be 
linear, single degree of freedom orthogonal contrasts were also performed to compare 
individual treatment means.     
 
RESULTS AND DISCUSSION 
 
Diet Composition 
     Nutrient composition of corn silage, mixed mostly legume silage, and wheat straw 
were relatively uniform between weekly samples of each forage type.  Mixed 
concentrate ingredients were delivered to the farm in one load, and weekly samples 
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were similar in chemical composition.  In vitro digestibility (24 h) of the corn silage, 
mixed mostly legume silage, and wheat straw were 79.8%, 77.3%, and 29%.   
     Chemical composition of the TMR concentrate and forages is presented in Table 5.  
The formulated CP content of the TMR was 14.4%, however, the mixed mostly 
legume silage varied from formulation through the experimental period.  The actual 
CP content of the diet and orts were 15.6% and 14.9%, respectively, thus the CP of the 
diet was higher than planned.   
 
Feed Intake  
     All cows remained in good health for the duration of the experiment, and DMI was 
not dramatically suppressed for any extended time during continuous infusions.  Dry 
matter intake, feed efficiency (FE), milk yield, and composition are presented in Table 
6.  Average DMI was 25.7 ± 1.4 kg/d among treatments.  Cows infused with Pro 
consumed significantly less DM than cows on control (C) and His (H) treatments (P < 
0.05), and tended to consume less DM than cows on the His and Pro (H+P) treatment 
(P < 0.10).  Although dietary AA imbalances have been shown to decrease feed intake 
in nonruminant species (Harper et al., 1970), AA imbalances in ruminant species are 
not commonly observed due to the consistency of the AA profile of microbial protein 
(Allen, 2000).  It is unlikely that Pro infusion caused an AA imbalance mainly due to 
lack of supporting evidence and the assumption that animals are able to cope with 
NEAA imbalances better than with EAA imbalances (Harper et al., 1970).  According 
to Bruckental et al. (1991), there was no significant difference between DMI of control 
and Pro infused cows.  More studies in which Pro and other NEAA are infused 
individually might lead to a more conclusive scheme of this effect on feed intake.   
Vanhatalo et al. (1999) observed slightly higher (P = 0.05) total DMI with His 
infusions as compared with the control.  In similar His infusion studies, average DMI  
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Table 5. Chemical composition of feedstuffs used in this infusion experiment.   
 
Variable Corn silage Mixed mostly legume silage Concentrate 
    
DM, % 40.1 35.9 91.8 
CP, % DM 8.5 21.9 20.6 
Soluble P, % CP 61.6 68.8 31.7 
NDF, % DM 37.3 43.2 23.0 
ADF, % DM 22.4 32.6 12.2 
Lignin, % DM 2.8 6.9 -- 
Crude fat, % DM 2.8 4.2 -- 
    
Calcium, % DM 0.16 1.51 1.38 
Phosphorus, % DM 0.25 0.37 0.50 
Magnesium, % DM 0.13 0.33 0.42 
Potassium, % DM 1.01 2.56 0.93 
Sodium, % DM 0.03 0.06 1.03 
    
24 h IVTD, % DM 79.8 77.3 -- 
24 h NDFD, % DM 45.8 47.8 -- 
    
NEL, Mcal/kg 1.5 1.4 1.9 
 
Chemical composition was determined by the Dairy One Forage Laboratory, Ithaca, 
NY. 
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Table 6. Least squares means for dry matter intake, feed efficiency (FE), milk yield, 
and milk composition of cows fed a common diet and infused abomasally with water 
(C), histidine (H), proline (P), or a combination of both AA (H+P). 
 
 Treatment  
Variable C H H+P P SE P1 
       
DMI, kg/d 26.6a 26.3ab 25.1bc 24.8c 0.5 0.04 
FE, kg 3.5% FCM/ 
kg DM 
1.95b 1.92b 1.95b 2.11a 0.08 0.07 
       
Yield       
   Milk, kg/d 50.2 49.6 48.0 48.7 1.7 0.44 
   3.5% FCM, kg/d 51.8 50.6 49.0 52.4 2.5 0.34 
   Fat, g/d 1871.7†‡ 1804.6†‡ 1736.9† 1929.7‡ 116.1 0.29 
   Lactose, g/d 2433.9 2427.5 2324.3 2423.9 94.2 0.36 
   Protein, g/d 1471.8† 1473.6† 1369.8‡ 1409.7†‡ 74.2 0.25 
       
Milk composition, %       
   Fat 3.70 3.60 3.63 3.95 0.15 0.29 
   Lactose 4.85b 4.89b 4.83b 4.97a 0.03 0.01 
   Protein 2.93 2.96 2.85 2.89 0.06 0.33 
   NPN 0.133b 0.135ab 0.135ab 0.144a 0.003 0.11 
   Urea, mg/dl 8.7 9.7 7.9 10.0 0.9 0.51 
 
a,b,cLeast squares means within rows were separated by linear contrasts; different 
superscripts differ (P ≤ 0.05)  
†,‡ Different superscripts differ (P ≤ 0.10) 
1Main effect of treatment. 
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was relatively the same for control and His treatments (Korhonen et al., 2000; 
Huhtanen et al., 2002).   
 
Milk Yield and Composition 
     Despite the lower CP content of the diet and the intensive nature of the 
experimental procedures, milk yield was maintained at a high level for the duration of 
the experiment (Table 4).  Milk yield and 3.5% fat corrected milk (FCM) averaged 
49.1 ± 3.5 and 51.0 ± 5.3 kg/d, respectively, and were not significantly different 
among treatments.  The lack of difference between milk yield of C and P treatments is 
consistent with results of Bruckental et al. (1991), in which daily milk yield did not 
differ between Control and Pro infused cows, in both early and mid lactation.  
According to data from an experiment in which goats were infused into the duodenum 
with Pro, milk yield was not significantly different between Control and Pro 
treatments (Alumot et al., 1983).   
     Abomasal His infusion (6.0 and 6.5 g/d) has been shown to increase milk yield in 
dairy cows by up to 1.8 kg/d (Vanhatalo et al., 1999; Korhonen et al., 2000; Huhtanen 
et al., 2002).  In an experiment involving infusion of a mixture of AA including and 
excluding His into the abomasum of lactating goats, milk yield was depressed (P = 
0.08) when His was excluded from the AA infusate (Bequette et al., 2000).  The 
authors imposed a single EAA limitation in goats and observed an increase in milk 
yield when the deficiency was corrected.  According to these studies in which His was 
limiting in both lactating dairy cows and goats, correction of the limitation through 
postruminal supplementation of His resulted in increased milk yields.  Results from 
the current study imply that postruminal supply of His had no effect on milk 
production in high producing dairy cows fed corn silage based diets and thus, was not 
first limiting.   
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     Protein and fat content of milk were not affected by treatments (P = 0.33 and 0.29 
for protein and fat, respectively).  Infusion of Pro alone increased lactose percentage 
(P = 0.01); however lactose yield was not affected by treatments.  Results of treatment 
contrasts showed that fat yield during Pro infusion (1929.7 g/d) tended to be higher (P 
≤ 0.10) than during His plus Pro infusion (1736.9 g/d).  There were no other 
significant differences among other treatments.  The protein yield for the cows on the 
H and H+P treatments tended to be more (P ≤ 0.10) than those on the H+P treatment, 
with no other significant differences.  There was no overall effect of treatment on NPN 
and MUN concentration of milk (P = 0.11 and 0.51 for NPN and MUN, respectively).  
However, when linear contrasts were performed between individual treatment means 
for NPN, the means for treatments H and H+P tended to be lower (P ≤ 0.10) than for 
treatment P, and mean for Control was less (P ≤ 0.05) than for treatment P.     
     Most research suggests that dietary protein has only minor effects on protein and 
fat content in milk (Emery, 1978; McCrae et al., 1987; Sutton, 1989), and this is most 
likely due to the low efficiency of transfer rates (25 to 30%) of dietary protein to milk 
(Bequette et al., 1998; Jenkins and McGuire, 2006) and that milk protein output is 
energy driven.  However, increasing postruminal supply of AA is of interest, due to 
the positive responses in milk yield and protein yield observed when casein was 
infused into the abomasum or duodenum of lactating dairy cows (Clark, 1975; Schwab 
et al., 1976; Raggio et al., 2006).  Productive responses to increased postruminal 
supply of individual AA are variable depending on the AA, protein and energy content 
of the ration, level of milk production, and method of supplementation (Cant et al., 
2003).  Although abomasal infusion of His has been shown to increase protein yield 
and decrease fat yield in milk of dairy cows (Vanhatalo et al., 1999; Korhonen et al., 
2000; Huhtanen et al., 2002), this was not observed in the present study.  Based on AA 
subtraction experiments in which a complete mixture of AA minus His was infused 
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into either the abomasum or an external iliac artery of lactating dairy cows, a 
significant increase in fat content of milk was observed with the His lacking infusate 
as compared with the complete mixture of AA (Cant et al., 2001; Weekes et al., 2006).   
     Milk composition responses to Pro infusion were unexpected, especially the 
observed increase (P = 0.01) in lactose content.  Reviews outlining the effect of diet 
on milk composition emphasize that lactose content was not significantly changed by 
dietary manipulations, aside from extreme or unusual feeding situations (Sutton, 1989; 
Jenkins and McGuire, 2006).  Palmiter (1969) suggested that lactose content is 
affected by concentrations of other osmoregulators, including Na+ and Cl- ions, in 
milk.  It has been shown that somatic cell count (SCC) is negatively associated with 
lactose content in milk across a variety of ruminant species (Vanlandingham et al., 
1941; Leitner et al., 2004a; Leitner et al., 2004b).  However, there were no significant 
differences in SCC among treatments of the current study.  Intracellular synthesis of 
Pro in the mammary gland requires α-ketoglutarate and NADPH, both of which are 
involved in the Krebs cycle (Basch et al., 1997).  It is possible that Pro infusion might 
have altered intracellular metabolism in the mammary gland to spare Krebs cycle 
intermediates, providing for more galactose for lactose synthesis.  Although lactose 
yield was similar (P = 0.56) across treatments, longer experimental periods might have 
resulted in a shift in mammary metabolism that could have led to greater milk and 
lactose yields.      
     Fat yield of cows infused with Pro tended to be higher than that of cows infused 
with His and Pro simultaneously (643.24 vs. 578.97 for P and H+P, respectively; P ≤ 
0.10).  Elevated milk fat percentage, and not fat yield, was observed with duodenal 
infusion of Pro in lactating goats and cows (Alumot et al., 1983; Bruckental et al., 
1991).  The mechanism behind the increase in fat content remains unclear, although 
the authors have suggested that this response is indicative of improved utilization of 
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available energy for production.  It has been suggested that a shift in intracellular 
mammary metabolism in response to a change in postruminal supply of AA might 
provide more milk fat precursors or NADPH to facilitate higher rates of lipogenesis 
(Weekes et al., 2006).  It appears that the mammary gland reacted differently to 
infusion of His plus Pro and that inclusion of His in the infusate mitigated any 
potential lipogenic effect of infusion of Pro alone.  Overall, milk and component 
yields were numerically lowest for the H+P treatment, which might suggest that an 
interaction of His and Pro metabolism in the mammary gland or in peripheral tissues 
does not provide for efficient use of nutrients for milk synthesis.  Both His and Pro 
can be transported across the mammary cell membrane via the sodium-dependent 
system A; however, His is considered to be transported primarily by system N 
(Baumrucker et al., 1985).  If competition between AA for a shared transport system 
occurs, then it is possible that this antagonism might affect AA supply for milk 
production (Bequette et al., 2003); however this proposed mechanism has yet to be 
substantiated.    
  
Feed Efficiency 
     There was a tendency (P = 0.07) for increased feed efficiency (FE) during Pro 
infusion (Table 4).  Feed efficiency, estimated as kg 3.5% FCM per kg DMI, is a basic 
measurement of the efficiency at which dietary energy is converted to milk.  
According to an experiment performed by Britt et al. (2003), FE was highly and 
positively correlated to total milk yield and negatively correlated with DIM and DMI.  
The cows used in the present study were in early lactation and converted DM to milk 
with efficiencies ranging from 1.92 to 2.11 kg 3.5% FCM/kg feed.  The slightly higher 
FE observed for animals infused with Pro was most likely due to their reduced DMI 
because no significant change in 3.5% FCM was observed.  Further work with more 
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animals would substantiate the observation that increased absorptive supply of Pro 
might improve 3.5% FCM feed efficiency by decreasing DMI.  Milk N:feed N ratios 
were 0.364, 0.362, 0.358, and 0.375 for treatments C, H, H+P, and P, respectively.           
 
Mammary Blood Flow 
     Mammary blood flow (MBF) was estimated using the Fick Principle, which is 
based on the plasma AV difference and output of Phe and Tyr in milk protein.  
Therefore, calculated values of MBF are not independent of measured AV differences 
and milk protein output of Phe and Tyr.  There was no treatment effect on absolute 
MBF, expressed as L blood/min.  Although MBF, expressed as L blood/L milk, was 
not significantly different across treatments, there was a 14% increase (694.8 vs. 606.8 
L blood/L milk for P and C, respectively) in MBF with P treatment as compared with 
the Control (P = 0.37).  There are limited studies in which Pro was infused into the 
duodenum of lactating cows and goats, and in those studies MBF was not significantly 
affected by Pro infusion (Alumot et al., 1983; Bruckental et al., 1991).  Although 
MBF was not significantly affected by treatment, the slightly higher MBF during Pro 
infusion might be biologically significant.  Bequette et al. (2000) showed that 
abomasal infusion of a mixture of AA lacking His in lactating goats elevated MBF by 
approximately 33%, as compared with MBF during infusion of a complete mixture of 
AA including His.  The authors speculated that MBF was up-regulated in order to 
maintain AA supply to the mammary gland when His was limiting or deficient.  The 
slight elevation in MBF observed during Pro infusion might have been a result of a 
change in the absorptive AA profile.  This change might have altered the pattern of 
AA supplied to the mammary gland, which in turn could have caused the mammary 
gland to up-regulate blood flow to ensure adequate supply of other AA for 
intracellular anabolic processes. 
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Figure 3. Mammary blood flow for each of the four treatments. Blood flow, which was 
estimated using the Fick Principle and Phe and Tyr as markers, is expressed as ml of 
blood per ml of milk, and values represent the LS mean  ± SE.  Experimental 
treatments were abomasal infusion of water (C), histidine (H), proline (P), or a 
combination of the two AA (H+P).   
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     Production of local vasoactive agents within the mammary gland influences the 
rate of MBF (Davis and Collier, 1985; Prosser et al., 1996).  Given this observation, 
then it is possible that rate of milk synthesis and intracellular mammary metabolism, 
which might affect the generation of these vasoactive substances, plays an important 
role in regulating nutrient flow to the mammary gland.  The vasorelaxant nitric oxide 
(NO), which is synthesized from Arg and the activity of NO synthase enzymes, is one 
potential regulator of MBF that has been shown to increase MBF in lactating goats 
(Lacasse et al., 1996).  Nitric oxide synthesis and intracellular Pro synthesis both 
utilize Arg as a precursor, and the enzymes that facilitate these processes have been 
identified in the parenchyma of mammary tissue (Verbeke et al., 1968; Clark et al., 
1975; Lacasse et al., 1996).  It is possible that if the Arg requirement for Pro synthesis 
in the mammary gland was reduced, more Arg might be available for synthesis of NO, 
polyamines, and other compounds, if the required enzymes were present and active.  
However, there was no evidence to support that postruminal supplementation of Pro 
decreased the Arg requirement for Pro synthesis or that mammary intracellular Arg 
metabolism is subject to major changes.    
             
Mammary Amino Acid Utilization  
     Indwelling intercostal artery catheters remained patent for the duration of the 
experiment, and arterial plasma concentrations of AA are presented in Table 7.  The 
arterial plasma concentration of His tended to be higher for His infusion than for both 
Control and Pro infusions (P ≤ 0.10) and was not significantly different between H 
and H+P treatments.  There was no significant effect of treatment on arterial 
concentrations of other EAA, with the exception of Cys (P = 0.01), which was lower 
during Pro infusion than during both Control and His infusions.  The arterial 
concentration of Lys, Thr, and Orn, arterial plasma concentration tended to be lower 
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Table 7. Least squares means for arterial plasma amino acids from cows fed the same 
total mixed ration and infused abomasally with water (C), histidine (H), proline (P), or 
a combination of both AA (H+P).    
 
 Treatment   
Variable C H H+P P SEM P1 
 (µM)   
EAA       
   Arg 57.5 54.5 52.9 54.8 5.9 0.70 
   Cys 14.7b 16.9a 15.3ab 12.2c 1.2 0.01 
   His 24.3† 36.8‡ 33.7†‡ 24.6† 4.0 0.12 
   Ile 81.2 76.3 75.4 77.2 4.4 0.71 
   Leu 97.4 81.5 80.6 87.5 8.0 0.38 
   Lys    76.6† 72.5†‡ 66.8‡ 71.9†‡ 5.7 0.37 
   Met 26.9 25.3 25.3 23.5 2.3 0.82 
   Phe 31.0 28.5 30.7 31.9 3.0 0.78 
   Thr 77.1† 70.0†‡ 61.5‡ 66.8†‡ 5.1 0.30 
   Trp 30.2 27.8 26.3 31.9 3.5 0.63 
   Val 180.3a 161.9ab 152.1b 167.5ab 8.7 0.17 
       
NEAA       
   Ala 223.7 212.9 205.0 213.5 15.5 0.62 
   Asn 39.3 36.2 36.5 37.4 3.4 0.77 
   Asp 7.4 8.2 9.0 9.4 1.0 0.40 
   Gln 232.2 221.2 218.3 224.0 16.0 0.54 
   Glu 57.2 58.9 59.2 57.8 4.0 0.78 
   Gly 393.0 350.6 372.1 399.4 33.4 0.68 
   Pro 107.7 103.7 94.6 93.9 15.3 0.80 
   Ser 92.9 82.6 85.4 89.0 5.0 0.58 
   Tyr 36.6 34.0 33.0 33.4 2.6 0.60 
        
   Cit 65.7 55.7 58.0 69.4 5.2 0.32 
   Orn 36.0† 29.8†‡ 28.8‡ 32.4†‡ 3.4 0.24 
 
a,b,cLeast squares means within rows were separated by linear contrasts; different 
superscripts differ (P ≤ 0.05)  
†,‡ Different superscripts differ (P ≤ 0.10) 
1Main effect of treatment. 
 
 
   47 
(P ≤ 0.10) during His + Pro infusion than during Control infusion.  Also, the mean for 
arterial concentration of Val was lower (P ≤ 0.05) during His + Pro infusion than 
during Control infusion.  The arterial plasma concentrations of NEAA were not 
significantly different between treatments with the exception that Orn concentration 
tended to be lower (P ≤ 0.10) for treatment H+P as compared with the Control.   
     An increase in the arterial plasma concentration of AA is commonly observed 
when the postruminal supply of those AA is increased (Spires et al., 1975; Guinard 
and Rulquin, 1994; Mackle et al., 1999).  Although arterial plasma concentration of 
His has been shown to increase with greater absorptive supply of His (Kim et al., 
2000; Korhonen et al., 2000), this response has not been well documented when Pro 
alone was infused.  Pro concentration in arterial plasma has been shown to either 
remain the same or increase with duodenal infusion of casein (Seymour et al., 1990; 
Guinard and Rulquin, 1994; Mackle et al., 2000), of which Pro comprises 
approximately 10% (Swaisgood, 1995).  The lack of an observed response in plasma 
Pro concentration to increased postruminal supply in the present experiment might 
reflect postabsorptive disposal of Pro.  If this were the case, it might have occurred 
because the Pro requirement for milk protein synthesis had been exceeded (Hanigan et 
al., 2001).  According to Hanigan et al., it appears that absorptive supply of AA affects 
systemic concentrations and might be one of many factors that influence net removal 
of AA by the udder.  Further work in this area would provide more information to 
determine the extent at which altered postruminal supply of one or more AA affects 
systemic AA concentrations and AA utilization by other tissues.      
     There was no overall treatment effect on AV differences or mammary uptake of 
AA, with the exception that uptake of Cys tended to be lower (P ≤ 0.10) during His + 
Pro infusion than during Control infusion (Tables 8 and 9).  The AV difference of Cys 
was lower (P ≤ 0.05) and AV difference of Cit tended to be lower (P ≤ 0.10) for  
   48 
 
 
Table 8. Least squares means for mammary arteriovenous difference of plasma amino 
acids from cows fed the same total mixed ration and infused abomasally with water 
(C), histidine (H), proline (P), or a combination of both AA (H+P).  
 
 Treatment   
Variable C H H+P P SEM P1 
 (µM)   
EAA       
   Arg 29.4 30.9 29.8 27.1 2.8 0.75 
   Cys 1.8a,† 1.2ab,†‡ 1.6ab,† 0.6b,‡ 0.3 0.15 
   His 9.8 10.6 10.0 9.7 1.2 0.89 
   Ile 33.0 31.3 32.5 26.5 4.1 0.64 
   Leu 50.0 49.2 47.3 44.2 5.6 0.83 
   Lys    41.1 42.8 38.5 36.6 4.5 0.60 
   Met 10.5 10.3 11.0 8.9 1.2 0.57 
   Phe 15.8 17.6 15.9 14.9 1.9 0.63 
   Thr 21.7 21.0 22.2 18.7 2.5 0.76 
   Trp 2.6 2.3 2.8 1.3 1.2 0.83 
   Val 41.8 40.5 41.9 31.2 4.8 0.39 
       
NEAA       
   Ala 46.4 46.0 45.7 31.9 9.4 0.69 
   Asn 8.3 6.1 9.1 7.9 1.8 0.66 
   Asp 1.7†‡ 1.7†‡ 2.2† 1.1‡ 0.3 0.34 
   Gln 52.2 48.5 51.0 35.6 7.7 0.51 
   Glu 36.5†‡ 41.5† 40.6†‡ 34.2‡ 2.6 0.19 
   Gly 23.3 -8.3 4.5 -15.7 12.8 0.34 
   Pro 13.4 23.3 15.7 6.9 8.9 0.68 
   Ser 22.8 21.2 22.6 19.4 4.5 0.78 
   Tyr 15.6 17.2 15.6 13.9 1.8 0.83 
        
   Cit 2.6† 0.7†‡ 1.8†‡ -2.0‡ 1.4 0.26 
   Orn 16.6 14.9 14.8 15.1 2.2 0.83 
 
a,b,cLeast squares means within rows were separated by linear contrasts; different 
superscripts differ (P ≤ 0.05)  
†,‡ Different superscripts differ (P ≤ 0.10) 
1Main effect of treatment. 
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Table 9. Least squares means for mammary amino acid uptake from cows fed the 
same total mixed ration and infused abomasally with water (C), histidine (H), proline 
(P), or a combination of both AA (H+P).  
 
 Treatment   
Variable C H H+P P SEM P1 
 (g/kg of milk)   
EAA       
   Arg 4.07 3.91 3.94 4.11 0.24 0.86 
   Cys 0.34a,† 0.22ab, †‡ 0.28ab,† 0.10b,‡ 0.05 0.09 
   His 1.21 1.17 1.19 1.30 0.09 0.32 
   Ile 3.45 3.16 3.27 2.99 0.22 0.44 
   Leu 5.19 4.67 4.77 5.02 0.34 0.42 
   Lys    4.76 4.54 4.38 4.68 0.35 0.76 
   Met 1.25 1.11 1.25 1.14 0.09 0.22 
   Phe 2.08 2.09 2.02 2.58 0.21 0.95 
   Thr 2.08† 1.79‡ 2.02†‡ 1.90†‡ 0.15 0.30 
   Trp 0.43 0.37 0.46 0.07 0.23 0.63 
   Val 3.92† 3.43†‡ 3.75†‡ 3.04‡ 0.33 0.18 
       
NEAA       
   Ala 3.26 2.95 3.16 2.01 0.65 0.52 
   Asn 1.13 0.79 1.14 1.15 0.20 0.45 
   Asp 0.18 0.16 0.21 0.12 0.03 0.21 
   Gln 6.08† 5.07†‡ 5.63†‡ 4.18‡ 0.72 0.31 
   Glu 4.33 4.41 4.49 4.60 0.28 0.89 
   Gly 0.51† -0.48†‡ 0.23†‡ -1.47‡ 0.67 0.29 
   Pro 1.27 2.09 1.38 0.54 0.70 0.54 
   Ser 1.88 1.57 1.89 1.69 0.31 0.25 
   Tyr 2.25 2.22 2.18 2.70 0.28 0.64 
       
   Cit 0.42† 0.14†‡ 0.23†‡ -0.37‡ 0.21 0.19 
   Orn 1.72 1.44 1.52 1.73 0.17 0.27 
 
a,b,cLeast squares means within rows were separated by linear contrasts; different 
superscripts differ (P ≤ 0.05)  
†,‡ Different superscripts differ (P ≤ 0.10) 
1Main effect of treatment. 
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treatment P than for treatment C.  When AV differences were compared between H+P 
and P, the AV differences of both Cys and Asp during His + Pro infusion tended to be 
higher (P ≤ 0.10) than during Pro infusion.  The AV difference of Glu tended to be 
higher (P ≤ 0.10) for treatment H (41.5 µMoles/L) than for treatment P (34.2 
µMoles/L).  When individual treatment means for mammary uptake of AA were 
evaluated, the most interesting differences were observed between treatments C and P.  
Uptake of Cit and Cys were lower (P ≤ 0.05) during Pro infusion, and uptake of Gly 
and Val tended to be lower (P ≤ 0.10) during Pro infusion, as compared with Control 
infusion.  Cys uptake by the mammary gland for treatment P tended to be lower than 
for treatment H+P, and Thr uptake for treatment H tended to be less than for treatment 
C.       
     Raggio et al. (2006) observed increased AV differences of all AA (P ≤ 0.05), 
except Asp and Glu, with duodenal infusion of casein in early lactation dairy cows.  In  
another experiment in which casein (500 g/d) plus BCAA (88 g/d) were infused into 
the abomasum of cows in late lactation, AA infusion did not result in significant 
changes in AV differences of any AA, with the exception of Val (Mackle et al., 2000).  
These authors observed that arterial concentrations and AV differences of EAA tended 
to be the lowest for the treatments that produced the highest milk protein yields, which 
does not support using these measurements to predict AA supply and to identify 
limiting AA for milk protein production (Mackle et al., 2000).              
     The results of the present experiment show that AV difference and mammary 
uptake of Arg were not affected (P = 0.75 and 0.86, respectively) by abomasal 
infusion of 20 g of Pro.  These observations are not consistent with data from other 
Pro infusion experiments performed using small groups of lactating cows (Bruckental 
et al., 1991) and goats (Alumot et al., 1983).  Bruckental et al. reported a 50% 
decrease in Arg uptake with infusion of 80 g of Pro in early and mid lactation dairy  
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cows, compared with the control.  These authors observed significantly lower AV 
difference of Arg during Pro infusion, and they reported no change in MBF between 
treatments.  Therefore, the significantly reduced Arg uptake associated with Pro 
infusion was mainly attributed to the lower AV difference.  In the present experiment, 
no differences in AV difference of Arg or MBF between C and P treatments were 
observed and could be due to the difference in the amount of Pro infused between the 
two experiments.  We infused a quarter of the amount infused by Bruckental et al. 
(1991).  Thus, we might not have provided enough to allow for the same effect on Arg 
uptake or the milk yield differences between studies were great enough to not impact 
Arg uptake.      
     It appears that abomasal infusion of Pro might have affected uptake of other AA, 
especially Cit, Cys, Gly, and Val.  These AA are extracted and utilized by the 
mammary gland for different purposes (Mepham, 1982), which makes it difficult to 
determine the mechanism by which Pro might be altering mammary uptake of these 
substrates.  Cit is an AA taken up by the mammary gland but not secreted in milk 
(Clark, 1975) and has been shown to be utilized to synthesize Pro and be oxidized to 
CO2 in perfused sheep and goat mammary epithelial cells (Roets et al., 1974).  The 
BCAA have been the subject of multiple experiments, because they are the primary 
AA in casein, are extracted by the mammary gland in excess of their output in milk 
and donate carbon to form TCA cycle intermediates, CO2, and NEAA in the mammary 
gland (Wohlt et al., 1977; Mepham, 1982; Bequette and Backwell, 1997; Mackle et 
al., 1999).  It is possible that increased absorptive supply of Pro might have altered 
certain metabolic pathways occurring in mammary cells, which caused a reduction in 
mammary uptake of other AA.  Fluctuations in intracellular and extracellular AA 
concentrations modulate AA transport (Bequette et al., 2003), however this does not 
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necessarily imply that changes in AA transport will result in higher milk protein 
synthesis. 
     Amino acid extraction rates, calculated by dividing the AV difference of an AA by 
its concentration in arterial plasma, were determined for all AA and presented in Table 
10.  There was no main effect of treatment for extraction efficiencies of AA (P > 
0.05), however there was a tendency for treatment differences (P ≤ 0.10) for extraction 
efficiency of His, Orn, Phe, and Val.  Considering the linear contrasts that were 
carried out among individual treatment means, His extraction was lower (P ≤ 0.05) 
during His infusion and His + Pro infusion than during Control infusion.  The constant 
AV difference was most likely responsible for the lower His extraction rate that was 
observed as absorptive supply of His was increased.  This effect is consistent with 
other AA infusion experiments in which postruminal infusion of an individual AA 
resulted in a decrease in extraction efficiency of that AA and a similar AV difference 
for that AA as compared with the control treatment (Varvikko et al., 1999; Vanhatalo 
et al., 1999; Korhonen et al., 2000).  Additionally, Bequette et al. (2000) reported a 
drastic increase in efficiency of removal of His by the mammary gland when His 
supply was limiting.          
     There were differences in individual treatment means of extraction efficiencies for 
two of the BCAA.  For Leu, extraction efficiency for treatment H tended to be higher 
(P ≤ 0.10) than for treatment C and P, separately.  Val extraction tended to be lower (P 
≤ 0.10) during Pro infusion (18.3%) as compared with during Control infusion 
(23.4%) and was lower (P ≤ 0.05) during Pro infusion than during His (24.9%) or 
His+Pro infusion (27.6%).  Although there were no significant differences among 
treatment means for Ile extraction, the rate of Ile extraction was numerically less 
during Pro infusion as compared with the other three treatments.  The BCAA represent 
approximately 22% of milk protein (Swaisgood, 1995) and are required by the 
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Table 10. Least squares means for extraction rates of plasma amino acids from cows 
fed the same total mixed ration and infused abomsally with water (C), histidine (H), 
proline (P), or a combination of both AA (H+P).  
 
 Treatment   
Variable C H H+P P SEM P1 
 (%)   
EAA       
   Arg 52.3 57.2 56.9 50.1 4.6 0.27 
   Cys 12.2 7.4 10.6 6.3 2.3 0.30 
   His 45.8a 29.0b 29.5b 40.5ab 5.6 0.10 
   Ile 40.8 40.2 43.2 34.3 4.1 0.38 
   Leu 51.3† 60.2‡ 58.7†‡ 51.0† 4.8 0.14 
   Lys    53.9 58.9 57.3 51.3 4.5 0.43 
   Met 39.7 41.2 43.8 37.9 4.7 0.73 
   Phe 51.0ab,† 61.4a,‡ 52.2ab,† 46.9b,† 4.1 0.07 
   Thr 28.4† 30.2†‡ 36.5‡ 27.5† 2.9 0.21 
   Trp 9.0 8.4 10.8 0.5 4.7 0.47 
   Val 23.4ab,† 24.9a,† 27.6a,† 18.3b,‡ 2.2 0.06 
       
NEAA       
   Ala 21.0 21.4 22.1 15.6 3.8 0.61 
   Asn 21.2 16.0 25.6 21.0 3.6 0.43 
   Asp 23.4ab,† 20.8ab,†‡ 24.6a,† 11.5b,‡ 3.7 0.13 
   Gln 22.8 21.9 23.3 16.6 3.3 0.56 
   Glu 63.9†‡ 70.3† 68.6† 60.2‡ 2.9 0.16 
   Gly 6.6 -2.7 1.2 -4.7 3.8 0.35 
   Pro 12.0 20.2 17.3 9.6 7.2 0.69 
   Ser 25.0 24.5 26.2 21.9 4.9 0.79 
   Tyr 43.1 50.1 47.3 41.5 3.3 0.31 
        
   Cit 4.5† 1.0†‡ 2.9†‡ -3.2‡ 2.2 0.23 
   Orn 46.5a,‡ 49.9ab,† 51.3b,† 46.1a,‡ 3.4 0.07 
 
a,b,cLeast squares means within rows were separated by linear contrasts; different 
superscripts differ (P ≤ 0.05)  
†,‡ Different superscripts differ (P ≤ 0.10) 
1Main effect of treatment. 
 
 
 
   54 
mammary gland in amounts exceeding what is secreted in milk protein due to the high 
level of oxidation and utilization in secretory cells (Wohlt et al., 1977; Mepham, 
1982).  They are catabolized in mammary cells to yield organic acids, carbon 
skeletons for NEAA synthesis, and CO2, (Mepham, 1982; Bequette et al., 1998).  Pro 
synthesis in mammary epithelial cells involves several important enzymes, reducing 
equivalents, and α-ketoglutarate (Basch et al., 1995; Basch et al., 1996), which is a 
TCA cycle intermediate that can be produced by carbon skeletons donated by BCAA.  
Decreasing intracellular Pro synthesis might spare α-ketoglutarate, which could 
continue in its role in the TCA cycle, which could produce glucose or galactose to 
contribute to lactose synthesis.  It appears there might be an interaction between Pro 
synthesis and production of TCA cycle intermediates, although the mechanism by 
which increased absorptive supply of individual AA might affect intracellular 
metabolism and extraction efficiency of other AA is unclear.                       
     Contrasts between individual treatment means showed that extraction efficiency of 
some of the NEAA were different between certain treatments.  The extraction 
efficiency of Asp tended to be lower for P than for treatment C and was significantly 
lower for treatment H+P.  Also, there was a tendency for Glu extraction to be less 
during Pro infusion than during either His or His+Pro infusion.  Orn extraction tended 
to be higher (P ≤ 0.10) for treatment H+P as compared with treatment C and tended to 
be lower (P ≤ 0.10) for treatment P as compared with treatment H.   
     In the case of Cit, the extraction rate during Pro infusion was negative and tended 
to be lower than during abomasal infusion of water.  The negative extraction rate 
associated with Pro infusion was due to the negative AV difference of this AA.  
Unlike Arg, Cit does not occur in milk; therefore, if extracted by the mammary gland, 
it is either broken down or converted into other AA within cells (Roets et al., 1974).   
It was observed that Cit uptake was reduced during Pro infusion and appears to be 
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produced since a negative extraction rate implies production, and it is possible that the 
lower extraction rate is a parallel effect.  The negative AV difference of Cit during Pro 
infusion might indicate that with increased absorptive supply of Pro, Cit was being 
produced within mammary cells, most likely via activity of NO synthase enzymes that 
convert Arg to Cit while producing NO gas (Wu and Morris, 1998).  In this case, 
intracellular concentration of Cit might have affected uptake or transport of this AA 
into the cell (Bequette et al., 2003).  There is evidence to support that Arg deprivation 
can reduce expression of an inducible isoform of NO synthase (Morris et al., 2006).  
The mechanism by which these processes might be occurring due to a change in 
absorptive supply of Pro seems complex and might relate to the proposed notion that 
increasing Pro supply to the mammary gland reduces the Arg requirement for 
endogenous Pro synthesis (Bruckental et al., 1991). 
     The current experiment indicates that there is some effect of altering absorptive 
supply of His and Pro on uptake and utilization of other AA by mammary epithelial 
cells.  Analysis and interpretation of the mammary AA utilization data was difficult 
because although there were differences in individual treatment means of certain 
parameters, the sample size of cows was small, and drawing mechanistic conclusions 
requires further work.  
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CHAPTER 3: CONCLUSION 
 
     The objectives of this research were to determine the effects of abomasal infusion 
of the AA His and Pro on milk composition and mammary AA utilization in high 
producing lactating dairy cows fed corn silage based rations.  The four animals that 
were used for the experiment maintained a high level of milk production.  The results 
of this study suggest several key pieces of information.  First, although His has been 
shown to be a limiting AA for milk and milk protein production in dairy cows being 
fed grass silage based diets, it does not appear that a His limitation occurs in high 
producing dairy cows being fed corn silage based commercial rations common to the 
Northeast US dairy industry.  When 10 g of His was infused into the abomasum of 
high producing lactating dairy cows during this experiment, milk yield and milk 
protein yield were not different than values for the Control treatment.  Although His 
infusion increased the plasma concentration of His, extraction efficiency of His was 
modestly reduced, which might suggest that the mammary gland was able to regulate 
uptake of this AA and that under current experimental conditions was not a limiting 
AA for milk yield or milk protein synthesis.  In the small group of cows that were 
used for the experiment, there appeared to be no benefit of increasing postruminal His 
supply, in terms of improving milk production, milk protein synthesis, or mammary 
AA utilization.      
     The feed intake and efficiency responses that were observed during abomasal 
infusion of Pro were unexpected.  Abomasal infusion of Pro resulted in reduced DMI, 
which after taking into account the similar milk production among treatments, caused 
an increase in conversion of feed to milk.  Percentage of lactose in milk was higher 
during Pro infusion as compared with the Control infusion.  Although the difference in 
MBF between the Pro and Control treatments was not significant, there was a 14% 
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increase when Pro was infused.  However, this apparent difference in MBF should be 
considered carefully because of the small sample size of cows used in the experiment 
and also because of the MBF estimation technique, which is partially based on the AV 
difference of Phe and Tyr across the mammary gland.  With respect to mammary AA 
utilization, abomasal infusion of Pro did not decrease Arg uptake, which is 
inconsistent with previously published work, however it modestly altered mammary 
uptake and extraction rate of Cit.  Pro infusion also altered uptake of Cys, Val, and 
Gly.  Under the conditions of this experiment, abomasal infusion of Pro did not 
increase milk protein content or yield, nor did it alter Arg uptake by the mammary 
gland.  More research on increased absorptive supply of Pro, using more animals, is 
needed in order to validate feed intake and mammary AA utilization responses that 
were observed in this experiment.   
     Abomasal infusion of His and Pro simultaneously did not improve milk production 
or milk protein synthesis.  DMI was slightly lower during His + Pro infusion, however 
feed efficiency was similar to the value for the Control.  For high producing lactating 
dairy cows fed corn silage based rations, there seems to be no benefit of increasing the 
postruminal supply of these two AA together.  Supplementing Pro alone resulted in a 
greater improvement in feed efficiency.  Infusion of His + Pro resulted in a lower 
extraction rate of His, as compared with the control, although generally, it did not alter 
AV difference across the mammary gland, extraction efficiency, or mammary uptake 
of AA.  
     This study emphasizes the effectiveness of feeding rations that are formulated to 
provide adequate metabolizable energy and protein to support a high level of milk 
production without overfeeding N.  The actual CP content of the experimental ration 
was 15.6%, and MP supply was balanced not to exceed predicted requirements.  Milk 
production was maintained at a high level under these dietary conditions.  Milk N:feed 
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N ratios were 0.364, 0.362, 0.358, and 0.375 for treatments C, H, H+P, and P, 
respectively.  The results of this experiment provide a framework to investigate the 
potential benefits of increasing absorptive supply of Pro.  There might be significant 
practical implications in the dairy industry if supplementation of Pro could 
consistently improve feed efficiency by reducing DMI, although the mechanism by 
which this might be occurring is unknown.     
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